Immunohistochemical analysis showed that TRIM2 was highly expressed in tumor tissues in a study of TRIM2 in CRC that also included in vitro cell proliferation assays, cell adhesion assays, and Transwell migration and invasion assays. This evidence concerns the gene TRIM2 and colorectal carcinoma.